Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Developing vaccines against epidemic-prone emerging infectious diseases.

Autor: Bernasconi, Valentina, Kristiansen, Paul A., Whelan, Mike, Román, Raúl Gómez, Bettis, Alison, Yimer, Solomon Abebe, Gurry, Céline, Andersen, Svein R., Yeskey, Debra, Mandi, Henshaw, Kumar, Arun, Holst, Johan, Clark, Carolyn, Cramer, Jakob P., Røttingen, John-Arne, Hatchett, Richard, Saville, Melanie, Norheim, Gunnstein

Publikováno v: Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz; Jan2020, Vol. 63 Issue 1, p65-73, 9p

Endothelial Adhesion Molecule Expression and Its Inhibition by Recombinant Bactericidal/Permeability-Increasing Protein Are Influenced by the Capsulation and Lipooligosaccharide Structure ofNeisseria meningitidis

Autor: Dixon, Garth L. J., Heyderman, Robert S., Kotovicz, Karolena, Jack, Dominic L., Andersen, Svein R., Vogel, Ulrich, Frosch, Matthias, Klein, Nigel

Publikováno v: Infection and Immunity; November 1999, Vol. 67 Issue: 11 p5626-5633, 8p

Short-chain lipopolysaccharide mutants of serogroup B Neisseria meningitidis of potential value for production of outer membrane vesicle vaccines

Autor: Andersen, Svein R., Bjune, Gunnar, Lyngby, Janne, Bryn, Klaus, Jantzen, Erik

Publikováno v: Microbial Pathogenesis; September 1995, Vol. 19 Issue: 3 p159-168, 10p

Developing vaccines against epidemic-prone emerging infectious diseases.

Autor: Bernasconi V; Coalition for Epidemic Preparedness Innovation (CEPI), Marcus Thranes Gate 2, 0473, Oslo, Norway., Kristiansen PA; Coalition for Epidemic Preparedness Innovation (CEPI), Marcus Thranes Gate 2, 0473, Oslo, Norway., Whelan M; Coalition for Epidemic Preparedness Innovation (CEPI), NW1 2BE, London, UK., Román RG; Coalition for Epidemic Preparedness Innovation (CEPI), Marcus Thranes Gate 2, 0473, Oslo, Norway., Bettis A; Coalition for Epidemic Preparedness Innovation (CEPI), Marcus Thranes Gate 2, 0473, Oslo, Norway., Yimer SA; Coalition for Epidemic Preparedness Innovation (CEPI), Marcus Thranes Gate 2, 0473, Oslo, Norway., Gurry C; Coalition for Epidemic Preparedness Innovation (CEPI), Marcus Thranes Gate 2, 0473, Oslo, Norway., Andersen SR; Coalition for Epidemic Preparedness Innovation (CEPI), Marcus Thranes Gate 2, 0473, Oslo, Norway., Yeskey D; Coalition for Epidemic Preparedness Innovation (CEPI), Washington, DC, USA., Mandi H; Coalition for Epidemic Preparedness Innovation (CEPI), Marcus Thranes Gate 2, 0473, Oslo, Norway., Kumar A; Coalition for Epidemic Preparedness Innovation (CEPI), Marcus Thranes Gate 2, 0473, Oslo, Norway., Holst J; Coalition for Epidemic Preparedness Innovation (CEPI), Marcus Thranes Gate 2, 0473, Oslo, Norway., Clark C; Coalition for Epidemic Preparedness Innovation (CEPI), Marcus Thranes Gate 2, 0473, Oslo, Norway., Cramer JP; Coalition for Epidemic Preparedness Innovation (CEPI), NW1 2BE, London, UK., Røttingen JA; Coalition for Epidemic Preparedness Innovation (CEPI), Marcus Thranes Gate 2, 0473, Oslo, Norway.; Research Council of Norway, Lysaker, Norway., Hatchett R; Coalition for Epidemic Preparedness Innovation (CEPI), Marcus Thranes Gate 2, 0473, Oslo, Norway., Saville M; Coalition for Epidemic Preparedness Innovation (CEPI), NW1 2BE, London, UK., Norheim G; Coalition for Epidemic Preparedness Innovation (CEPI), Marcus Thranes Gate 2, 0473, Oslo, Norway. gunnstein.norheim@cepi.net.

Publikováno v: Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz [Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz] 2020 Jan; Vol. 63 (1), pp. 65-73.